Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ray Borrow and Shamez Ladhani.
Ray Borrow
Connection Strength
4.748
Shamez Ladhani
  1. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017). BMC Infect Dis. 2019 Jun 14; 19(1):522.
    View in: PubMed
    Score: 0.828
  2. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England. J Infect. 2021 11; 83(5):573-580.
    View in: PubMed
    Score: 0.240
  3. Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England. Emerg Infect Dis. 2021 Sep; 27(9):2495-2497.
    View in: PubMed
    Score: 0.238
  4. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020. EClinicalMedicine. 2021 Jul; 37:100948.
    View in: PubMed
    Score: 0.237
  5. Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers. J Infect. 2021 05; 82(5):162-169.
    View in: PubMed
    Score: 0.234
  6. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study. Lancet Child Adolesc Health. 2021 06; 5(6):417-427.
    View in: PubMed
    Score: 0.234
  7. Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16. Euro Surveill. 2019 Jan; 24(1).
    View in: PubMed
    Score: 0.201
  8. Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016. Pediatr Infect Dis J. 2018 07; 37(7):697-703.
    View in: PubMed
    Score: 0.194
  9. Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015. Vaccine. 2018 06 18; 36(26):3876-3881.
    View in: PubMed
    Score: 0.191
  10. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018 04; 18(4):441-451.
    View in: PubMed
    Score: 0.188
  11. Growing evidence supports 4CMenB effectiveness. Lancet Infect Dis. 2018 04; 18(4):370-371.
    View in: PubMed
    Score: 0.188
  12. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. J Infect. 2018 04; 76(4):335-341.
    View in: PubMed
    Score: 0.187
  13. Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014. Clin Infect Dis. 2017 10 01; 65(7):1191-1198.
    View in: PubMed
    Score: 0.184
  14. Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab. Pediatrics. 2017 Sep; 140(3).
    View in: PubMed
    Score: 0.182
  15. Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015-2016. Emerg Infect Dis. 2017 07; 23(7):1184-1187.
    View in: PubMed
    Score: 0.181
  16. Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014. Clin Infect Dis. 2017 Jul 15; 65(2):308-314.
    View in: PubMed
    Score: 0.181
  17. Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak? J Infect. 2017 08; 75(2):95-103.
    View in: PubMed
    Score: 0.180
  18. Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. Lancet Infect Dis. 2017 07; 17(7):754-762.
    View in: PubMed
    Score: 0.178
  19. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study. Lancet. 2016 12 03; 388(10061):2775-2782.
    View in: PubMed
    Score: 0.172
  20. Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 Jul; 22(7):928.
    View in: PubMed
    Score: 0.060
  21. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021 06; 3(6):e360-e370.
    View in: PubMed
    Score: 0.059
  22. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England. J Infect. 2021 07; 83(1):104-111.
    View in: PubMed
    Score: 0.059
  23. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. 2021 05; 22(5):620-626.
    View in: PubMed
    Score: 0.058
  24. B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open. 2018 07 10; 8(7):e020988.
    View in: PubMed
    Score: 0.049
  25. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017 10; 2(10):e473-e482.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.